Google
×
AllNewsImagesShopping Maps Videos Books
Search tools
Archives
  • Recent
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
  • Archives
Sorted by relevance
Clear

The Sinovac-CoronaVac COVID-19 vaccine: What you need to know

World Health Organization (WHO)
How efficacious is the vaccine? A large phase 3 trial in Brazil showed that two doses, administered at an interval of 14 days, had an efficacy...
29 months ago

Sinovac (CoronaVac) COVID-19 vaccine: Safety and side effects

MedicalNewsToday
According to the data, the most common side effect reported within 28 days of the second dose was injection-site pain (13–21%, depending on the dosing schedule)...
41 months ago

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients

Nature
We show a reduction in immunity 6-months of Sinovac-CoronaVac 2nd dose, particularly in males and those under immunosuppressives therapies, without a...
26 months ago

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

The New England Journal of Medicine
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine...
40 months ago

How the Sinovac Vaccine Works (Published 2022)

The New York Times
Once vaccinated with CoronaVac, the immune system can respond to an infection of live coronaviruses. B cells produce antibodies that stick to the invaders.
47 months ago

Sinovac: Brazil results show Chinese vaccine 50.4% effective

BBC
Last week researchers at the Butantan Institute, which has been conducting the trials in Brazil, announced that the vaccine had a 78% efficacy...
46 months ago

Thailand sticks with Sinovac vaccine after cases of 'stroke-like' side effects

Reuters
Thailand will continue to use COVID-19 vaccine from China's Sinovac Biotech (SVA.O) following six reports of unusual "stroke-like" side...
43 months ago

How China’s Sinovac compares with BioNTech’s mRNA vaccine

The Economist
With two doses, the BioNTech shot was 75-96% protective across age groups. Sinovac, however, had a range of 44-94%. For those aged 80 and above,...
31 months ago

WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations

World Health Organization (WHO)
WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities...
42 months ago

Sinovac CoronaVac COVID-19 vaccine - Interim Recommendations and more information

Pan American Health Organization (PAHO)
These WHO interim recommendations on the use of the Sinovac vaccine against COVID-19 were developed on the basis of advice issued by the...
42 months ago